Previously, we showed that secreted gelsolin (sGSN), an extracellular protein that circulates in plasma and is secreted by tumor cells, severs F-actin and blocks DNGR-1 ligand binding, dampening anti-cancer immunity and the efficacy of immunogenic anti-cancer therapies (31, 32). This evidence concerns the gene GSN and cancer.